Veeva Systems and BioMarin Pharmaceutical announced a long-term enterprise agreement that builds upon their long-standing relationship.
The expanded partnership will help BioMarin increase speed, agility, operational efficiency, and optimize the healthcare professional and patient experience by further leveraging and providing strategic input into Veeva's software, data, services, and consulting products.
"This strategic partnership marks an important next step in our digital evolution," said Alexander Hardy, President and Chi ef Executive Officer of BioMarin. "We are excited by the opportunity to combine our scientific capabilities with Veeva's technological leadership that we believe will enable us to bring our transformative medicines more quickly to patients around the world."
"Our partnership with BioMarin has always been guided by a shared set of values, including product excellence, value realization, and customer success," said Veeva CEO Peter Gassner. "Building on this foundation, I look forward to how we can further support BioMarin as they advance important new medicines and reach even more patients around the world."
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from American Pharmaceutical Review – all delivered right to your inbox!
Sign up now!